{
    "organizations": [],
    "uuid": "0f24957363c31ab018363188d46f5c4fb0e86175",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-veloxis-submits-application-to-fda/brief-veloxis-submits-application-to-fda-seeking-new-indication-for-envarsus-xr-idUSFWN1QP0U1",
    "ord_in_thread": 0,
    "title": "BRIEF-Veloxis ‍submits application to FDA seeking new indication for Envarsus XR​",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 7 (Reuters) - Veloxis Pharmaceuticals A/S:\n* VELOXIS PHARMACEUTICALS - ‍SUBMITTED SUPPLEMENTAL NEW DRUG APPLICATION TO U.S. FOOD & DRUG ADMINISTRATION SEEKING A NEW INDICATION FOR ENVARSUS XR​ Source text for Eikon: Further company coverage:\n ",
    "published": "2018-03-08T09:11:00.000+02:00",
    "crawled": "2018-03-08T17:34:41.012+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "veloxis",
        "pharmaceutical",
        "veloxis",
        "pharmaceutical",
        "supplemental",
        "new",
        "drug",
        "application",
        "food",
        "drug",
        "administration",
        "seeking",
        "new",
        "indication",
        "envarsus",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}